Annual Report 2024

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY For the year ended 31 December 2024 48 The United Laboratories International Holdings Limited Annual Report 2024 Attributable to owners of the Company Share capital Share premium Treasury stock Special reserve Capital reserve Share-based compensation reserve Foreign exchange reserve Retained profits Subtotal Non- controlling interests Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note b) (Note a) At 1 January 2023 16,965 3,722,482 – 277,100 1,254,210 – 9,109 5,328,220 10,608,086 1,345 10,609,431 Exchange differences arising on translation of foreign operations – – – – – – 425 – 425 – 425 Profit (loss) for the year – – – – – – – 2,701,350 2,701,350 (505) 2,700,845 Total comprehensive income (expense) for the year – – – – – – 425 2,701,350 2,701,775 (505) 2,701,270 Capital contribution from the non-controlling interest of a subsidiary – – – – – – – – – 12,000 12,000 Dividends recognised as distribution (Note 15) – – – – – – – (581,448) (581,448) – (581,448) Recognition of share-based compensation expense – – – – – 6,365 – – 6,365 – 6,365 Appropriations – – – – 164,967 – – (164,967) – – – At 31 December 2023 16,965 3,722,482 – 277,100 1,419,177 6,365 9,534 7,283,155 12,734,778 12,840 12,747,618 Exchange differences arising on translation of foreign operations – – – – – – 549 – 549 – 549 Profit (loss) for the year – – – – – – – 2,659,704 2,659,704 (1,883) 2,657,821 Total comprehensive income (expense) for the year – – – – – – 549 2,659,704 2,660,253 (1,883) 2,658,370 Capital contribution from the non-controlling interest of a subsidiary – – – – – – – – – 36,000 36,000 Dividends recognised as distribution (Note 15) – – – – – – – (1,017,535) (1,017,535) – (1,017,535) Repurchase of shares – – (36,465) – – – – – (36,465) – (36,465) Transaction cost attributable to repurchase of shares – – (112) – – – – – (112) – (112) Recognition of share-based compensation expense – – – – – 47,364 – – 47,364 – 47,364 Vesting of shares – – 35,539 – – (24,693) – (10,846) – – – Appropriations – – – – 162,188 – – (162,188) – – – At 31 December 2024 16,965 3,722,482 (1,038) 277,100 1,581,365 29,036 10,083 8,752,290 14,388,283 46,957 14,435,240 Notes: (a) Capital reserve represents the PRC statutory reserve which must be provided for before declaring dividends to the shareholders as approved by the board of directors in accordance with the PRC regulations applicable to the Company’s PRC subsidiaries until the fund reaches 50% of the registered capital of the respective subsidiaries. (b) Included in special reserve is an amount of RMB203,263,000 which represents the portion of registered capital of the two PRC subsidiaries contributed by certain beneficial owners of the Company. The remaining amount of RMB73,837,000 represents the difference between the carrying amount of the non-controlling interests acquired and the fair value of considerations paid for acquisition of additional interests in subsidiaries in prior years.